{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:34:35Z","timestamp":1790786075865,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00134-017-4919-5","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T04:41:05Z","timestamp":1506055265000},"page":"1751-1763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":260,"title":["Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017"],"prefix":"10.1007","volume":"43","author":[{"given":"Djillali","family":"Annane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Pastores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Balk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albertus","family":"Beishuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Briegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Carcillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Christ-Crain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Marik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Umberto Meduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith M.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greet","family":"Van den Berghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,21]]},"reference":[{"issue":"6","key":"4919_CR1","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","volume":"36","author":"PE Marik","year":"2008","unstructured":"Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, Keh D, Briegel J, Beishuizen A, Dimopoulou I, Tsagarakis S, Singer M, Chrousos GP, Zaloga G, Bokhari F, Vogeser M, American College of Critical Care Medicine (2008) Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 36(6):1937\u20131949","journal-title":"Crit Care Med"},{"key":"4919_CR2","unstructured":"Cochrane Collaboration (2012) Cochrane: review manager. Edition 5.2. Edited by Centre TNC. Cochrane Collaboration, Copenhagen"},{"key":"4919_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","volume":"7","author":"BJ Shea","year":"2007","unstructured":"Shea BJ, Grimshaw JM, Wells GA et al (2007) Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 7:10","journal-title":"BMC Med Res Methodol"},{"key":"4919_CR4","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, Cochrane Bias Methods Group; Cochrane Statistical Methods Group et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"key":"4919_CR5","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwel P (2016) The Newcastle--Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: \n                        www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\n                        \n                    . Accessed 21 Nov 2016"},{"key":"4919_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-3-25","volume":"3","author":"P Whiting","year":"2003","unstructured":"Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25","journal-title":"BMC Med Res Methodol"},{"issue":"9","key":"4919_CR7","doi-asserted-by":"crossref","first-page":"e1000094","DOI":"10.1371\/journal.pmed.1000094","volume":"6","author":"BP Kavanagh","year":"2009","unstructured":"Kavanagh BP (2009) The GRADE system for rating clinical guidelines. PLoS Med 6(9):e1000094","journal-title":"PLoS Med"},{"issue":"7","key":"4919_CR8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","volume":"66","author":"JC Andrews","year":"2013","unstructured":"Andrews JC, Schunemann HJ, Oxman AD et al (2013) GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation\u2019s direction and strength. J Clin Epidemiol 66(7):726\u2013735","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"4919_CR9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2016","unstructured":"Rhodes A, Evans LE, Alhazzani W et al (2016) Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock. Intensive Care Med 43(3):304\u2013377","journal-title":"Intensive Care Med"},{"issue":"2","key":"4919_CR10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W et al (2016) Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101(2):364\u2013389","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4919_CR11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00003246-200301000-00022","volume":"31","author":"PE Marik","year":"2003","unstructured":"Marik PE, Zaloga GP (2003) Adrenal insufficiency during septic shock. Crit Care Med 31(1):141\u2013145","journal-title":"Crit Care Med"},{"key":"4919_CR12","doi-asserted-by":"crossref","unstructured":"de Jong MF, Molenaar N, Beishuizen A, Groeneveld AB (2015) Diminished adrenal sensitivity to endogenous and exogenous adrenocorticotropic hormone in critical illness: a prospective cohort study. Crit Care 19:1. Erratum in: Crit Care. 2015;19:313","DOI":"10.1186\/s13054-014-0721-8"},{"issue":"6","key":"4919_CR13","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/TA.0000000000000221","volume":"76","author":"Y Yang","year":"2014","unstructured":"Yang Y, Liu L, Jiang D, Wang J, Ye Z, Ye J, Chao J, Zhao M, Ao D, Qiu H (2014) Critical illness-related corticosteroid insufficiency after multiple traumas: a multicenter, prospective cohort study. J Trauma Acute Care Surg 76(6):1390\u20131396","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"4919_CR14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1164\/rccm.200911-1738OC","volume":"182","author":"K Menon","year":"2010","unstructured":"Menon K, Ward RE, Lawson ML, Gaboury I, Hutchison JS, Hebert PC, Canadian Critical Care Trials Group (2010) A prospective multicenter study of adrenal function in critically ill children. Am J Respir Crit Care Med 182(2):246\u2013251","journal-title":"Am J Respir Crit Care Med"},{"key":"4919_CR15","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMoa020266","volume":"350","author":"AH Hamrahian","year":"2004","unstructured":"Hamrahian AH, Oseni TS, Arafah BM (2004) Measurements of serum free cortisol in critically ill patients. N Engl J Med 350:1629\u20131638","journal-title":"N Engl J Med"},{"key":"4919_CR16","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s00134-011-2342-x","volume":"37","author":"N Molenaar","year":"2011","unstructured":"Molenaar N, Groeneveld ABJ, Dijstelbloem HM et al (2011) Assessing adrenal insufficiency of corticosteroid secretion using free versus total cortisol levels in critical illness. Intensive Care Med 37:1986\u20131993","journal-title":"Intensive Care Med"},{"key":"4919_CR17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1530\/EJE-14-0576","volume":"171","author":"Z Tarjanyi","year":"2014","unstructured":"Tarjanyi Z, Montsko G, Kenyeres P et al (2014) Free and total cortisol levels are useful prognostic markers in critically ill patients: a prospective observational study. Eur J Endocrinol 171:751\u2013759","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"4919_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10253890701365527","volume":"11","author":"DS Jessop","year":"2008","unstructured":"Jessop DS, Turner-Cobb JM (2008) Measurement and meaning of salivary cortisol: a focus on health and disease in children. Stress 11(1):1\u201314","journal-title":"Stress"},{"issue":"18","key":"4919_CR19","first-page":"3730","volume":"20","author":"A Galbois","year":"2016","unstructured":"Galbois A, Obadia E, Chalumeau-Lemoine L, Chelha R (2016) Using serum total cortisol assays overstates the adrenal insufficiency prevalence in cirrhotic patients. Eur Rev Med Pharmacol Sci 20(18):3730\u20133731","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"4919_CR20","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2010.01.026","volume":"52","author":"A Galbois","year":"2010","unstructured":"Galbois A, Rudler M, Massard J et al (2010) Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred. J Hepatol 52(6):839\u2013845","journal-title":"J Hepatol"},{"issue":"5","key":"4919_CR21","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1378\/chest.11-0448","volume":"140","author":"RM Estrada-Y-Martin","year":"2011","unstructured":"Estrada-Y-Martin RM, Orlander PR (2011) Salivary cortisol can replace free serum cortisol measurements in patients with septic shock. Chest 140(5):1216\u20131222","journal-title":"Chest"},{"issue":"2","key":"4919_CR22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0022-4731(87)90071-9","volume":"26","author":"JL Coolens","year":"1987","unstructured":"Coolens JL, Van Baelen H, Heyns W (1987) Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem 26(2):197\u2013202","journal-title":"J Steroid Biochem"},{"issue":"1","key":"4919_CR23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1210\/jc.2005-0265","volume":"91","author":"JT Ho","year":"2006","unstructured":"Ho JT, Al-Musalhi H, Chapman MJ et al (2006) Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab 91(1):105\u2013114","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4919_CR24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1210\/jc.2015-1700","volume":"101","author":"NS Ospina","year":"2016","unstructured":"Ospina NS, Al Nofal A, Bancos I et al (2016) ACTH stimulation tests for the diagnosis of adrenal insufficiency: systematic review and meta-analysis. J Clin Endocrinol Metab 101(2):427\u2013434","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4919_CR25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1055\/s-0032-1304320","volume":"44","author":"RB Moraes","year":"2012","unstructured":"Moraes RB, Friedman G, Tonietto T, Saltz H, Czepielewski M (2012) Comparison of low and high dose cosyntropin stimulation tests in the diagnosis of adrenal insufficiency in septic shock patients. Horm Metab Res 44(4):296\u2013301","journal-title":"Horm Metab Res"},{"key":"4919_CR26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF01720688","volume":"17","author":"AJ Schneider","year":"1991","unstructured":"Schneider AJ, Voerman HJ (1991) Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids. Intensive Care Med 17:436\u2013437","journal-title":"Intensive Care Med"},{"key":"4919_CR27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archsurg.1993.01420180075014","volume":"128","author":"WA Baldwin","year":"1993","unstructured":"Baldwin WA, Allo M (1993) Occult hypoadrenalism in critically ill patients. Arch Surg 128:673\u2013676","journal-title":"Arch Surg"},{"key":"4919_CR28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2125.1998.00833.x","volume":"46","author":"D Annane","year":"1998","unstructured":"Annane D, Bellissant E, S\u00e9bille V et al (1998) Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 46:589\u2013597","journal-title":"Br J Clin Pharmacol"},{"key":"4919_CR29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00003246-200301000-00022","volume":"31","author":"PE Marik","year":"2003","unstructured":"Marik PE, Zaloga GP (2003) Adrenal insufficiency during septic shock. Crit Care Med 31:141\u2013145","journal-title":"Crit Care Med"},{"key":"4919_CR30","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","volume":"288","author":"D Annane","year":"2002","unstructured":"Annane D, Sebille V, Charpentier C et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862\u2013871","journal-title":"JAMA"},{"key":"4919_CR31","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1503\/cmaj.090707","volume":"182","author":"YM Arabi","year":"2010","unstructured":"Arabi YM, Aljumah A, Dabbagh O et al (2010) Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ 182:1971\u20131977","journal-title":"CMAJ"},{"key":"4919_CR32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung CL, Annane D, Keh D et al (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111\u2013124","journal-title":"N Engl J Med"},{"key":"4919_CR33","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.2016.14799","volume":"316","author":"D Keh","year":"2016","unstructured":"Keh D, Trips E, Marx G et al (2016) Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial. JAMA 316:1775\u20131785","journal-title":"JAMA"},{"key":"4919_CR34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5811\/westjem.2013.7.6828","volume":"15","author":"CR Wira","year":"2014","unstructured":"Wira CR, Dodge K, Sather J, Dziura J (2014) Meta-analysis of protocolized goal-directed hemodynamic optimization for the management of severe sepsis and septic shock in the Emergency Department. West J Emerg Med 15:51\u201359","journal-title":"West J Emerg Med"},{"key":"4919_CR35","first-page":"CD002243","volume":"12","author":"D Annane","year":"2015","unstructured":"Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y (2015) Corticosteroids for treating sepsis. Cochrane Database Syst Rev 12:CD002243","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"4919_CR36","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","volume":"29","author":"DC Angus","year":"2001","unstructured":"Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303\u20131310","journal-title":"Crit Care Med"},{"issue":"16","key":"4919_CR37","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16):1546\u20131554","journal-title":"N Engl J Med"},{"key":"4919_CR38","unstructured":"Torio CM, Andrews RM (2011) National Inpatient Hospital Costs: the most expensive conditions by Payer, 2011: Statistical Brief #160. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb\u20132013 Aug"},{"issue":"10","key":"4919_CR39","first-page":"159","volume":"113","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann C, Thomas-Rueddel DO, Hartmann M et al (2016) Hospital incidence and mortality rates of sepsis. Dtsch Arztebl Int 113(10):159\u2013166","journal-title":"Dtsch Arztebl Int"},{"issue":"9453","key":"4919_CR40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(04)17667-8","volume":"365","author":"D Annane","year":"2005","unstructured":"Annane D, Bellisant E, Cavaillon JM (2005) Septic shock. Lancet 365(9453):63\u201378","journal-title":"Lancet"},{"issue":"2","key":"4919_CR41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/cc2374","volume":"8","author":"H Prigent","year":"2004","unstructured":"Prigent H, Maxime V, Annane D (2004) Clinical review: corticotherapy in sepsis. Crit Care 8(2):122\u2013129","journal-title":"Crit Care"},{"key":"4919_CR42","first-page":"CD002243","volume":"12","author":"D Annane","year":"2015","unstructured":"Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y (2015) Corticosteroids for treating sepsis. Cochrane Database Syst Rev. 12:CD002243","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"4919_CR43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13054-017-1659-4","volume":"21","author":"B Gibbison","year":"2017","unstructured":"Gibbison B, L\u00f3pez-L\u00f3pez JA, Higgins JP, Miller T, Angelini GD, Lightman SL, Annane D (2017) Corticosteroids in septic shock: a systematic review and network meta-analysis. Crit Care 21(1):78","journal-title":"Crit Care"},{"key":"4919_CR44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13063-016-1365-6","volume":"17","author":"K O\u2019Hearn","year":"2016","unstructured":"O\u2019Hearn K, McNally D, Choong k, On behalf of the Canadian Critical Care Trials Group et al (2016) Steroids in fluid and\/or vasoactive infusion dependent pediatric shock: study protocol for a randomized controlled trial. Trials 17:238","journal-title":"Trials"},{"issue":"6","key":"4919_CR45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/PCC.0000000000001121","volume":"18","author":"K Menon","year":"2017","unstructured":"Menon K, McNally D, O\u2019Hearn K, Canadian Critical Care Trials Group et al (2017) A randomized controlled trial of corticosteroids in pediatric septic shock: a pilot feasibility study. Pediatr Crit Care Med 18(6):505\u2013512","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"4919_CR46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","volume":"20","author":"S Tongyoo","year":"2016","unstructured":"Tongyoo S, Permpikul C, Mongkolpun W, Vattanavanit V, Udompanturak S, Kocak M, Meduri GU (2016) Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care 20(1):329","journal-title":"Crit Care"},{"issue":"2","key":"4919_CR47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/INF.0000000000001380","volume":"36","author":"A El-Nawawy","year":"2017","unstructured":"El-Nawawy A, Khater D, Omar H, Wali Y (2017) Evaluation of early corticosteroid therapy in management of pediatric septic shock in pediatric intensive care patients: a randomized clinical study. Pediatr Infect Dis J 36(2):155\u2013159","journal-title":"Pediatr Infect Dis J"},{"key":"4919_CR48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13613-016-0147-3","volume":"6","author":"D Annane","year":"2016","unstructured":"Annane D, Brun Buisson C, Cariou A, The APROCCHSS Investigators for the TRIGGERSEP Network et al (2016) Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial. Ann Intensive Care 6:43","journal-title":"Ann Intensive Care"},{"issue":"22","key":"4919_CR49","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","volume":"366","author":"VM Ranieri","year":"2013","unstructured":"Ranieri VM, Thompson BT, Barie PS et al (2013) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366(22):2055\u20132064","journal-title":"N Engl J Med"},{"issue":"2","key":"4919_CR50","first-page":"83","volume":"15","author":"B Venkatesh","year":"2013","unstructured":"Venkatesh B, Myburgh J, Finfer S et al (2013) The ADRENAL study protocol: adjunctive corticosteroid treatment in critically ill patients with septic shock. Crit Care Resusc 15(2):83\u201388","journal-title":"Crit Care Resusc"},{"issue":"8","key":"4919_CR51","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani G, Laffey JG, Pham T, LUNG SAFE Investigators; ESICM Trials Group et al (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315(8):788\u2013800","journal-title":"JAMA"},{"issue":"12","key":"4919_CR52","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1097\/01.CCM.0000248727.29055.25","volume":"34","author":"DC Angus","year":"2006","unstructured":"Angus DC, Clermont G, Linde-Zwirble WT, Musthafa AA, Dremsizov TT, Lidicker J, Lave JR, NO-06 Investigators (2006) Healthcare costs and long-term outcomes after acute respiratory distress syndrome: a phase III trial of inhaled nitric oxide. Crit Care Med 34(12):2883\u20132890","journal-title":"Crit Care Med"},{"issue":"3","key":"4919_CR53","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1513\/AnnalsATS.201610-792OC","volume":"14","author":"AD Hill","year":"2017","unstructured":"Hill AD, Fowler RA, Burns KE et al (2017) Long-term outcomes and health care utilization after prolonged mechanical ventilation. Ann Am Thorac Soc 14(3):355\u2013362","journal-title":"Ann Am Thorac Soc"},{"issue":"7","key":"4919_CR54","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1164\/rccm.201512-2343OC","volume":"194","author":"MS Herridge","year":"2016","unstructured":"Herridge MS, Chu LM, Matte A, RECOVER Program Investigators (Phase 1: towards RECOVER); Canadian Critical Care Trials Group et al (2016) The RECOVER program: disability risk groups and 1-year outcome after 7 or more days of mechanical ventilation. Am J Respir Crit Care Med 194(7):831\u2013844","journal-title":"Am J Respir Crit Care Med"},{"key":"4919_CR55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.280.2.159","volume":"280","author":"GU Meduri","year":"1998","unstructured":"Meduri GU, Headley AS, Golden E et al (1998) Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 280:159\u2013165","journal-title":"JAMA"},{"issue":"16","key":"4919_CR56","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","volume":"354","author":"KP Steinberg","year":"2006","unstructured":"Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M, National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354(16):1671\u20131684","journal-title":"N Engl J Med"},{"issue":"4","key":"4919_CR57","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1378\/chest.06-2100","volume":"131","author":"GU Meduri","year":"2007","unstructured":"Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R (2007) Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 131(4):954\u2013963","journal-title":"Chest"},{"key":"4919_CR58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejcdt.2013.02.013","volume":"6291","author":"NA Rezk","year":"2013","unstructured":"Rezk NA, Ibrahim AM (2013) Effects of methylprednisolone in early ARDS. Egypt J Chest Dis Tuberc 6291:167\u2013172","journal-title":"Egypt J Chest Dis Tuberc"},{"issue":"3","key":"4919_CR59","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","volume":"171","author":"M Confalonieri","year":"2005","unstructured":"Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della Porta R, Giorgio C, Blasi F, Umberger R, Meduri GU (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171(3):242\u2013248","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4919_CR60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.CCM.0000194723.78632.62","volume":"34","author":"D Annane","year":"2006","unstructured":"Annane D, S\u00e9bille V, Bellissant E, Ger-Inf-05 Study Group (2006) Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 34(1):22\u201330","journal-title":"Crit Care Med"},{"issue":"5","key":"4919_CR61","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00134-015-4095-4","volume":"42","author":"GU Meduri","year":"2016","unstructured":"Meduri GU, Bridges L, Shin MC et al (2016) Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients\u2019 data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med 42(5):829\u2013840","journal-title":"Intensive Care Med"},{"issue":"3","key":"4919_CR62","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00134-014-3613-0","volume":"41","author":"GU Meduri","year":"2015","unstructured":"Meduri GU, Eltorky MA (2015) Understanding ARDS-associated fibroproliferation. Intensive Care Med 41(3):517\u2013520","journal-title":"Intensive Care Med"},{"issue":"3","key":"4919_CR63","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1164\/ajrccm\/144.3_Pt_1.586","volume":"144","author":"LS Greos","year":"1991","unstructured":"Greos LS, Vichyanond P, Bloedow DC, Irvin CG, Larsen GL, Szefler SJ, Hill MR (1991) Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis. Am Rev Respir Dis 144(3):586\u2013592","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"4919_CR64","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00000542-200210000-00010","volume":"97","author":"S Hoen","year":"2002","unstructured":"Hoen S, Asehnoune K, Brailly-Tabard S et al (2002) Cortisol response to corticotropin stimulation in trauma patients: influence of hemorrhagic shock. Anesthesiology 97(4):807\u2013813","journal-title":"Anesthesiology"},{"issue":"12","key":"4919_CR65","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/jama.2011.360","volume":"305","author":"A Roquilly","year":"2011","unstructured":"Roquilly A, Mahe PJ, Seguin P et al (2011) Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA 305(12):1201\u20131209","journal-title":"JAMA"},{"issue":"9","key":"4919_CR66","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S2213-2600(14)70144-4","volume":"2","author":"K Asehnoune","year":"2014","unstructured":"Asehnoune K, Seguin P, Allary J, Corti-TC Study Group et al (2014) Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial. Lancet Respir Med 2(9):706\u2013716","journal-title":"Lancet Respir Med"}],"updated-by":[{"DOI":"10.1007\/s00134-018-5071-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000}}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-017-4919-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-017-4919-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-017-4919-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T07:24:06Z","timestamp":1512977046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-017-4919-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,21]]},"references-count":66,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4919"],"URL":"https:\/\/doi.org\/10.1007\/s00134-017-4919-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00134-018-5071-6","asserted-by":"object"}]},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,21]]}}}